FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199590410> ?p ?o ?g. }

• W3199590410 abstract "Abstract Background A high proportion of people receiving both oral and injectable opioid agonist treatment report concurrent use of stimulants (i.e. cocaine and or amphetamines), which has been associated with higher rates of continued illicit opioid use and treatment dropout. A recent randomized controlled trial demonstrated the effectiveness of dextroamphetamine (a prescribed stimulant) at reducing craving for and use of cocaine among patients receiving injectable opioid agonist treatment. Following this evidence, dextroamphetamine has been prescribed to patients with stimulant use disorder at a clinic in Vancouver. This study investigates perceptions of the effectiveness of dextroamphetamine from the perspective of these patients. Methods Data were collected using small focus groups and one-on-one interviews with patients who were currently or formerly receiving dextroamphetamine ( n = 20). Thematic analysis was conducted using an iterative approach, moving between data collection and analysis to search for patterns in the data across transcripts. This process led to the defining and naming of three central themes responding to the research question. Results Participants reported a range of stimulant use types, including cocaine ( n = 8), methamphetamine (n = 8), or both ( n = 4). Three central themes were identified as relating to participants’ perceptions of the effectiveness of the medication: 1) achieving a substitution effect (i.e. extent to which dextroamphetamine provided a substitution for the effect they received from use of illicit stimulants); 2) Reaching a preferred dose (i.e. speed of titration and effect of the dose received); and 3) Ease of medication access (i.e. preference for take home doses (i.e. carries) vs. medication integrated into care at the clinic). Conclusion In the context of continued investigation of pharmacological treatments for stimulant use disorder, the present study has highlighted how the study of clinical outcomes could be extended to account for factors that contribute to perceptions of effectiveness from the perspective of patients. In practice, elements of treatment delivery (e.g. dosing and dispensation protocols) can be adjusted to allow for various scenarios (e.g. on site vs. take home dosing) by which dextroamphetamine and other pharmacological stimulants could be implemented to provide “effective” treatment for people with a wide range of treatment goals and needs." @default.
• W3199590410 created "2021-09-27" @default.
• W3199590410 creator A5005839687 @default.
• W3199590410 creator A5007218450 @default.
• W3199590410 creator A5011987577 @default.
• W3199590410 creator A5023960678 @default.
• W3199590410 creator A5037329912 @default.
• W3199590410 creator A5042459472 @default.
• W3199590410 creator A5058783833 @default.
• W3199590410 creator A5063225643 @default.
• W3199590410 creator A5068818684 @default.
• W3199590410 creator A5073167350 @default.
• W3199590410 creator A5075988695 @default.
• W3199590410 creator A5085855420 @default.
• W3199590410 date "2021-09-16" @default.
• W3199590410 modified "2023-09-30" @default.
• W3199590410 title "Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment" @default.
• W3199590410 cites W1966809753 @default.
• W3199590410 cites W1979290264 @default.
• W3199590410 cites W2004828581 @default.
• W3199590410 cites W2010098953 @default.
• W3199590410 cites W2045573797 @default.
• W3199590410 cites W2081497085 @default.
• W3199590410 cites W2081834159 @default.
• W3199590410 cites W2105534262 @default.
• W3199590410 cites W2114496529 @default.
• W3199590410 cites W2134299138 @default.
• W3199590410 cites W2141934239 @default.
• W3199590410 cites W2145470773 @default.
• W3199590410 cites W2156886964 @default.
• W3199590410 cites W2305718570 @default.
• W3199590410 cites W2315152690 @default.
• W3199590410 cites W2561496577 @default.
• W3199590410 cites W2561777796 @default.
• W3199590410 cites W2614461066 @default.
• W3199590410 cites W2623119427 @default.
• W3199590410 cites W2885545707 @default.
• W3199590410 cites W2912943603 @default.
• W3199590410 cites W2934837273 @default.
• W3199590410 cites W2973183464 @default.
• W3199590410 cites W2989300124 @default.
• W3199590410 cites W3002273049 @default.
• W3199590410 cites W3004992208 @default.
• W3199590410 cites W3010839704 @default.
• W3199590410 cites W3037807962 @default.
• W3199590410 cites W3038588160 @default.
• W3199590410 cites W3090373583 @default.
• W3199590410 cites W4253992626 @default.
• W3199590410 doi "https://doi.org/10.1186/s13011-021-00399-2" @default.
• W3199590410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8444161" @default.
• W3199590410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34530878" @default.
• W3199590410 hasPublicationYear "2021" @default.
• W3199590410 type Work @default.
• W3199590410 sameAs 3199590410 @default.
• W3199590410 citedByCount "8" @default.
• W3199590410 countsByYear W31995904102022 @default.
• W3199590410 countsByYear W31995904102023 @default.
• W3199590410 crossrefType "journal-article" @default.
• W3199590410 hasAuthorship W3199590410A5005839687 @default.
• W3199590410 hasAuthorship W3199590410A5007218450 @default.
• W3199590410 hasAuthorship W3199590410A5011987577 @default.
• W3199590410 hasAuthorship W3199590410A5023960678 @default.
• W3199590410 hasAuthorship W3199590410A5037329912 @default.
• W3199590410 hasAuthorship W3199590410A5042459472 @default.
• W3199590410 hasAuthorship W3199590410A5058783833 @default.
• W3199590410 hasAuthorship W3199590410A5063225643 @default.
• W3199590410 hasAuthorship W3199590410A5068818684 @default.
• W3199590410 hasAuthorship W3199590410A5073167350 @default.
• W3199590410 hasAuthorship W3199590410A5075988695 @default.
• W3199590410 hasAuthorship W3199590410A5085855420 @default.
• W3199590410 hasBestOaLocation W31995904101 @default.
• W3199590410 hasConcept C126322002 @default.
• W3199590410 hasConcept C15744967 @default.
• W3199590410 hasConcept C170493617 @default.
• W3199590410 hasConcept C2776145449 @default.
• W3199590410 hasConcept C2777193897 @default.
• W3199590410 hasConcept C2779418921 @default.
• W3199590410 hasConcept C2780557958 @default.
• W3199590410 hasConcept C2781063702 @default.
• W3199590410 hasConcept C42219234 @default.
• W3199590410 hasConcept C513476851 @default.
• W3199590410 hasConcept C71924100 @default.
• W3199590410 hasConcept C98274493 @default.
• W3199590410 hasConceptScore W3199590410C126322002 @default.
• W3199590410 hasConceptScore W3199590410C15744967 @default.
• W3199590410 hasConceptScore W3199590410C170493617 @default.
• W3199590410 hasConceptScore W3199590410C2776145449 @default.
• W3199590410 hasConceptScore W3199590410C2777193897 @default.
• W3199590410 hasConceptScore W3199590410C2779418921 @default.
• W3199590410 hasConceptScore W3199590410C2780557958 @default.
• W3199590410 hasConceptScore W3199590410C2781063702 @default.
• W3199590410 hasConceptScore W3199590410C42219234 @default.
• W3199590410 hasConceptScore W3199590410C513476851 @default.
• W3199590410 hasConceptScore W3199590410C71924100 @default.
• W3199590410 hasConceptScore W3199590410C98274493 @default.
• W3199590410 hasFunder F4320313549 @default.
• W3199590410 hasIssue "1" @default.
• W3199590410 hasLocation W31995904101 @default.
• W3199590410 hasLocation W31995904102 @default.
• W3199590410 hasLocation W31995904103 @default.

• next